Journal profile · Biochemistry & Molecular Biology
Molecular Aspects of Medicine
ISSN 0098-2997 · eISSN 1872-9452 · Elsevier Ltd · NETHERLANDS · Bimonthly · Founded 1975
Molecular Aspects of Medicine: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 13.77; hybrid open access; APC about USD 5,220; median 115 days to acceptance (95 articles, last 24 months); community-reported acceptance: hard; 68 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Molecular Aspects of Medicine is published by Elsevier Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diverse Scientific and Economic Studies, Human auditory perception and evaluation and Educational Robotics and Engineering, together about 30% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Molecular Aspects of Medicine is a review journal for Physicians and Biomedical Scientists and an official journal of the International Union of Biochemistry and Molecular Biology. Molecular Aspects of Medicine aims to encourage the bridging of the gap between clinicians of all relevant specialities and biomedical scientists. The journal anticipates that most of the authors contributing to the series will be practising clinical scientists who will develop their own personal perspective as an extended review on the molecular aspects of a field of medicine in which they are working, addressing themselves both to the doctor who is ill-at-ease with basic science, and to the basic scientist with little awareness of the problems of clinical practice.It publishes articles on a spectrum of topics in medicine to illustrate not only the molecular insights that derive from the application of basic science, but also the variety of challenging problems that medicine is able to offer the basic scientist.Submissions on from biochemistry and molecular and cell biology to physiology, pharmacology and pathology are particularly welcomed.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Editor-in-chief George CalinPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named United States 14, Italy 8, Romania 5, United Kingdom 2, Mainland China 1 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance11.9%
- Human auditory perception and evaluationEngineering11.9%
- Educational Robotics and EngineeringComputer Science6.3%
- Antioxidant Activity and Oxidative StressMedicine6%
- Legal Cases and CommentaryMedicine5.5%
- Coenzyme Q10 studies and effectsBiochemistry, Genetics and Molecular Biology5.5%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology5.2%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 13.77LetPub ·
- Impact factor (publisher)
- 13.8Publisher website ·
- CiteScore 2026-06
- 21.6LetPub ·
- CiteScore (publisher)
- 21.6Publisher website ·
- SJR 2026-06
- 3.43LetPub ·
- SNIP 2026-06
- 2.71LetPub ·
- h-index
- 119LetPub ·
- h-index
- 196OpenAlex ·
- i10-index
- 1,081OpenAlex ·
- 2-year mean citedness
- 11.5OpenAlex ·
- Self-citation rate
- 0.7%LetPub ·
- Share of gold OA articles
- 42.07%LetPub ·
Volume
- Articles per year
- 59LetPub ·
Articles by year OpenAlex count · 1,597 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 40 | 16 | 58 |
| 2025 | 68 | 26 | 501 |
| 2024 | 55 | 33 | 1,315 |
| 2023 | 40 | 23 | 1,639 |
| 2022 | 60 | 40 | 2,403 |
| 2021 | 87 | 41 | 3,606 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
115 daysMedian, submission to acceptance · P25–P75 64 days – 154 days
- Acceptance to online
- median 8 days (95 articles)
- Submission to online
- median 126 days
- Sample
- 95 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9.1 weeksLetPub ·
- Average acceptance (community reports)
- HardLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 96 daysPublisher website ·
- Acceptance to publication
- 9 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,220 / EUR 4,880 / GBP 4,180 / JPY 647,440 | — | — | |
| Publisher website | USD 5,330 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- ≥ 1
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Highlights
- Optional
- Not considered
- unsolicited reviews
Article types accepted5
- opinionMAM only publishes invited special issues and review articles. The vast majority of the reviews published in this journal are independently commissioned by the …Length not stated
- reviewMAM only publishes invited special issues and review articles. The vast majority of the reviews published in this journal are independently commissioned by the …Length not stated
- review articleMAM only publishes invited special issues and review articles. The vast majority of the reviews published in this journal are independently commissioned by the …Length not stated
- review articlesMAM only publishes invited special issues and review articles.Length not stated
- special issuesMAM only publishes invited special issues and review articles.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Ltd
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1975
- ISSN
- 0098-2997
- Electronic ISSN
- 1872-9452
- Society / sponsor
- International Union of Biochemistry and Molecular Biology
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Molecular Aspects of Medicine
What CAS zone is Molecular Aspects of Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Molecular Aspects of Medicine is in Zone 2 of Medicine, and in Zone 2 of the minor category Biochemistry & Molecular Biology / Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Molecular Aspects of Medicine?
The latest impact factor listed by LetPub is 13.77; CiteScore 21.6, h-index 196.
How long does peer review take at Molecular Aspects of Medicine?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 64–154 days); authors report an average review time of about 9.1 weeks; the community-reported acceptance is “Hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Molecular Aspects of Medicine?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: ≥ 1; Reference style: Author–date; First submission: Free format: the journal's layout is not required; Highlights: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Molecular Aspects of Medicine based?
Of the 37 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (14), Italy (8) and Romania (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Molecular Aspects of Medicine?
According to LetPub and DOAJ records, Molecular Aspects of Medicine is indexed in SCIE and Scopus.
Is Molecular Aspects of Medicine open access, and what is the APC?
Molecular Aspects of Medicine is a hybrid journal. For open-access publication: APC about USD 5,220.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .